150 related articles for article (PubMed ID: 35822417)
1. The association between domestic hard water and eczema in adults from the UK Biobank cohort study.
Lopez DJ; Singh A; Waidyatillake NT; Su JC; Bui DS; Dharmage SC; Lodge CJ; Lowe AJ
Br J Dermatol; 2022 Nov; 187(5):704-712. PubMed ID: 35822417
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Atopic eczema and domestic water hardness.
McNally NJ; Williams HC; Phillips DR; Smallman-Raynor M; Lewis S; Venn A; Britton J
Lancet; 1998 Aug; 352(9127):527-31. PubMed ID: 9716057
[TBL] [Abstract][Full Text] [Related]
4. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema.
Chaumont A; Voisin C; Sardella A; Bernard A
Environ Res; 2012 Jul; 116():52-7. PubMed ID: 22591883
[TBL] [Abstract][Full Text] [Related]
5. Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A population-based cross-sectional study.
Perkin MR; Craven J; Logan K; Strachan D; Marrs T; Radulovic S; Campbell LE; MacCallum SF; McLean WH; Lack G; Flohr C;
J Allergy Clin Immunol; 2016 Aug; 138(2):509-16. PubMed ID: 27241890
[TBL] [Abstract][Full Text] [Related]
6. Water hardness and eczema at 1 and 4 y of age in the INMA birth cohort.
Font-Ribera L; Gracia-Lavedan E; Esplugues A; Ballester F; Jiménez Zabala A; Santa Marina L; Fernández-Somoano A; Sunyer J; Villanueva CM
Environ Res; 2015 Oct; 142():579-85. PubMed ID: 26298601
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial).
Jabbar-Lopez ZK; Ezzamouri B; Briley A; Greenblatt D; Gurung N; Chalmers JR; Thomas KS; Frost T; Kezic S; Common JEA; Danby S; Cork MJ; Peacock JL; Flohr C
Clin Exp Allergy; 2022 Mar; 52(3):405-415. PubMed ID: 34854157
[TBL] [Abstract][Full Text] [Related]
8. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET).
Thomas KS; Koller K; Dean T; O'Leary CJ; Sach TH; Frost A; Pallett I; Crook AM; Meredith S; Nunn AJ; Burrows N; Pollock I; Graham-Brown R; O'Toole E; Potter D; Williams HC
Health Technol Assess; 2011 Feb; 15(8):v-vi, 1-156. PubMed ID: 21324289
[TBL] [Abstract][Full Text] [Related]
9. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
10. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
11. Skin care interventions in infants for preventing eczema and food allergy.
Kelleher MM; Cro S; Cornelius V; Lodrup Carlsen KC; Skjerven HO; Rehbinder EM; Lowe AJ; Dissanayake E; Shimojo N; Yonezawa K; Ohya Y; Yamamoto-Hanada K; Morita K; Axon E; Surber C; Cork M; Cooke A; Tran L; Van Vogt E; Schmitt J; Weidinger S; McClanahan D; Simpson E; Duley L; Askie LM; Chalmers JR; Williams HC; Boyle RJ
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013534. PubMed ID: 33545739
[TBL] [Abstract][Full Text] [Related]
12. Interventions to reduce Staphylococcus aureus in the management of eczema.
George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
[TBL] [Abstract][Full Text] [Related]
13. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study.
Arshad SH; Tariq SM; Matthews S; Hakim E
Pediatrics; 2001 Aug; 108(2):E33. PubMed ID: 11483843
[TBL] [Abstract][Full Text] [Related]
14. Skin care interventions in infants for preventing eczema and food allergy.
Kelleher MM; Phillips R; Brown SJ; Cro S; Cornelius V; Carlsen KCL; Skjerven HO; Rehbinder EM; Lowe AJ; Dissanayake E; Shimojo N; Yonezawa K; Ohya Y; Yamamoto-Hanada K; Morita K; Axon E; Cork M; Cooke A; Van Vogt E; Schmitt J; Weidinger S; McClanahan D; Simpson E; Duley L; Askie LM; Williams HC; Boyle RJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013534. PubMed ID: 36373988
[TBL] [Abstract][Full Text] [Related]
15. Early exposure to solid foods and the development of eczema in children up to 4 years of age.
Sariachvili M; Droste J; Dom S; Wieringa M; Hagendorens M; Stevens W; van Sprundel M; Desager K; Weyler J
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 1):74-81. PubMed ID: 19573205
[TBL] [Abstract][Full Text] [Related]
16. Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial.
Jabbar-Lopez ZK; Gurung N; Greenblatt D; Briley A; Chalmers JR; Thomas KS; Frost T; Kezic S; Common JEA; Kong HH; Segre JA; Danby S; Cork MJ; Peacock JL; Flohr C
BMJ Open; 2019 Aug; 9(8):e027168. PubMed ID: 31434765
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of pre-incision antibiotics on children born by caesarean section: a longitudinal study based on UK electronic health records.
Šumilo D; Nirantharakumar K; Willis BH; Rudge GM; Martin J; Gokhale K; Thayakaran R; Adderley NJ; Chandan JS; Okoth K; Harris IM; Hewston R; Skrybant M; Deeks JJ; Brocklehurst P
Health Technol Assess; 2022 Jun; 26(30):1-160. PubMed ID: 35781133
[TBL] [Abstract][Full Text] [Related]
18. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
[TBL] [Abstract][Full Text] [Related]
19. House dust mite reduction and avoidance measures for treating eczema.
Nankervis H; Pynn EV; Boyle RJ; Rushton L; Williams HC; Hewson DM; Platts-Mills T
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008426. PubMed ID: 25598014
[TBL] [Abstract][Full Text] [Related]
20. Lifetime prevalence and determinants of hand eczema in an adolescent population in Germany: 15-year follow-up of the LISA cohort study.
Wang J; Tischer C; Standl M; Weidinger S; von Berg A; Herberth G; Yew YW; Heinrich J; Schmitt J; Apfelbacher C
J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):547-556. PubMed ID: 34779040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
